Literature DB >> 29036945

What's Your Micromort? A Patient-Oriented Analysis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

David A Sieber1, William P Adams2.   

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) continues to be a rare and elusive malignancy. Because BIA-ALCL does not behave like traditional lymphomas, additional research needs to be conducted to further delineate the lymphoproliferative nature of BIA-ALCL. An estimated 35 million women worldwide have breast implants and the total reported deaths from BIA-ALCL is 12 to date. The term micromort was introduced in 1979 by Ronald Howard as a person's risk of dying as 1 in a million. Drinking 0.5 L of wine or walking 17 miles all increase your risk of death by 1 micromort. Risk of death from BIA-ALCL is 0.4 micromorts for a woman having bilateral breast implants. This information is important for counseling new patients and those presenting with delayed onset seromas.
© 2017 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2017        PMID: 29036945     DOI: 10.1093/asj/sjx127

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  6 in total

Review 1.  Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.

Authors:  Daniel Fleming; Jason Stone; Patrick Tansley
Journal:  Aesthetic Plast Surg       Date:  2018-02-14       Impact factor: 2.326

2.  Breast Implant-Associated Anaplastic Large-Cell Lymphoma: A Case Report

Authors:  Hakan Kalyon; Erman Öztürk; Sıtkı Tuzlalı; Olga Meltem Akay; Burhan Ferhanoğlu
Journal:  Turk J Haematol       Date:  2019-07-24       Impact factor: 1.831

3.  Worldwide Experience of Breast Implant-Associated Large Cell Lymphoma (BIA-ALCL): Expert Panel and Roundtable Discussion.

Authors:  Jeffrey M Kenkel; Mark Magnusson; Nigel S G Mercer; William P Adams
Journal:  Aesthet Surg J Open Forum       Date:  2019-07-18

Review 4.  Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research.

Authors:  Anand K Deva; Suzanne D Turner; Marshall E Kadin; Mark R Magnusson; H Miles Prince; Roberto N Miranda; Giorgio G Inghirami; William P Adams
Journal:  Cancers (Basel)       Date:  2020-12-21       Impact factor: 6.639

Review 5.  Breast cancer recurrence after reconstruction: know thine enemy.

Authors:  Elizabeth A Brett; Matthias M Aitzetmüller; Matthias A Sauter; Georg M Huemer; Hans-Günther Machens; Dominik Duscher
Journal:  Oncotarget       Date:  2018-06-12

Review 6.  The State of the Art about Etiopathogenetic Models on Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): A Narrative Review.

Authors:  Roberto Cuomo
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.